Did you know that MSK conditions affect over 50% of adults and cost the health care system an estimated $420 billion annually— that’s more than diabetes, heart disease or any other chronic condition that plagues our population. And, in addition to the surgeries, PT, imaging and medication costs, you can add another $83B for indirect costs such as lost productivity, absenteeism, disability claims etc. MSK conditions simply cannot be overlooked when addressing cost-cutting strategies. Imagine a musculoskeletal health (MSK) strategy that finally bends both your cost and quality curves.
In this session, you’ll:
- Tackle the $280 PMPM challenge by exposing why traditional MSK programs fail
- Spot the silent cost driver hiding in plain sight (falls) and understand their $100+ PMPM impact
- Discover the ROI of digital-first prevention, with proven results in reducing utilization and improving outcomes
- See how fall prevention supports Stars, member satisfaction, and value-based care metrics (for today’s healthcare demands)
Speakers:
- Edward Likovich, PhD – CEO Nymbl Science
- Donna Baldwin, DO – Chief Medical Officer, Nymbl Science
Join us for this informative and practical session!